Black Diamond Therapeutics, Inc. SEC filings BDTX
Black Diamond Therapeutics, Inc. has 485 filings in SEC EDGAR's recent list, going back to Mar 28, 2017. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 29, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 21, 2026 | May 21, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 26, 2026 |
| S-8 | Employee stock plan registration | Mar 16, 2026 | — |
| 10-K | Annual report | Mar 16, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2026 | Mar 16, 2026 |
| EFFECT | Filing | Dec 3, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Dec 3, 2025 | Dec 3, 2025 |
| CORRESP | Letter to the SEC | Dec 1, 2025 | — |
| S-3 | Shelf registration | Nov 13, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2025 | Jun 12, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| ARS | Annual report to shareholders | Apr 18, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 18, 2025 | — |
| DEF 14A | Proxy statement | Apr 18, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 19, 2025 | Mar 18, 2025 |
| S-8 | Employee stock plan registration | Mar 6, 2025 | — |
| 10-K | Annual report | Mar 6, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Oct 7, 2024 | Oct 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 23, 2024 | Sep 23, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 6, 2024 | Jun 6, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 24, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 24, 2024 | — |
| DEF 14A | Proxy statement | Apr 24, 2024 | Jun 6, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 11, 2024 | Apr 10, 2024 |
| S-8 | Employee stock plan registration | Mar 12, 2024 | — |
| 10-K | Annual report | Mar 12, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2024 | Mar 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 18, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 13, 2023 | Dec 13, 2023 |
| 10-Q | Quarterly report | Nov 6, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 18, 2023 | Sep 15, 2023 |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Material agreement
|
Jun 30, 2023 | Jun 29, 2023 |
| 424B5 | Prospectus supplement | Jun 30, 2023 | — |
| 424B5 | Prospectus supplement | Jun 29, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 27, 2023 | Jun 27, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 16, 2023 | May 16, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| ARS | Annual report to shareholders | Apr 4, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 4, 2023 | — |
| DEF 14A | Proxy statement | Apr 4, 2023 | May 16, 2023 |
| S-8 | Employee stock plan registration | Mar 9, 2023 | — |
| 10-K | Annual report | Mar 9, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 19, 2022 | Dec 13, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 12, 2022 | Dec 12, 2022 |
| EFFECT | Filing | Nov 22, 2022 | — |
| CORRESP | Letter to the SEC | Nov 18, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 17, 2022 | — |
| S-3 | Shelf registration | Nov 14, 2022 | — |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2022 | Jun 7, 2022 |
| 10-Q | Quarterly report | May 11, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 11, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 25, 2022 | Apr 25, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 7, 2022 | Apr 5, 2022 |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| 10-K | Annual report | Mar 17, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Other events
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 22, 2021 | Nov 16, 2021 |
| 10-Q | Quarterly report | Nov 8, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2021 | Nov 8, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 10, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 5, 2021 | Aug 4, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2021 | Jun 18, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 19, 2021 | May 19, 2021 |
| 10-Q | Quarterly report | May 7, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 7, 2021 | May 7, 2021 |
| DEFA14A | Additional proxy material | Apr 29, 2021 | — |
| DEF 14A | Proxy statement | Apr 27, 2021 | Jun 18, 2021 |
| 8-K | Current report | Apr 21, 2021 | Apr 21, 2021 |
| S-8 | Employee stock plan registration | Mar 25, 2021 | — |
| 10-K | Annual report | Mar 25, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2021 | Mar 25, 2021 |
| 8-K |
Current report
Other events
|
Mar 15, 2021 | Mar 15, 2021 |
| 8-K |
Current report
Material agreement
|
Feb 1, 2021 | Feb 1, 2021 |
| S-3ASR | Automatic shelf registration | Feb 1, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Jan 20, 2021 | Jan 19, 2021 |
| 10-Q | Quarterly report | Nov 10, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2020 | Sep 25, 2020 |
| 10-Q | Quarterly report | Aug 11, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2020 | Aug 11, 2020 |
| 10-Q | Quarterly report | May 12, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 12, 2020 | May 12, 2020 |
| 10-K | Annual report | Mar 24, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2020 | Mar 24, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 3, 2020 | Feb 3, 2020 |
| S-8 | Employee stock plan registration | Jan 30, 2020 | — |
| 424B4 | Prospectus | Jan 30, 2020 | — |
| EFFECT | Filing | Jan 29, 2020 | — |
| S-1MEF | Filing | Jan 29, 2020 | — |
| CERT | Filing | Jan 29, 2020 | — |
| 8-A12B | Filing | Jan 27, 2020 | — |
| CORRESP | Letter to the SEC | Jan 27, 2020 | — |
| CORRESP | Letter to the SEC | Jan 27, 2020 | — |
| CORRESP | Letter to the SEC | Jan 21, 2020 | — |
| S-1/A | Amended registration statement | Jan 21, 2020 | — |
| CORRESP | Letter to the SEC | Jan 13, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 10, 2020 | — |
| S-1 | Registration statement | Jan 3, 2020 | — |
| DRS/A | Filing | Dec 13, 2019 | — |
| D | Filing | Dec 6, 2019 | — |
| DRSLTR | Filing | Oct 30, 2019 | — |
| DRS/A | Filing | Oct 30, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 17, 2019 | — |
| SEC STAFF LETTER | Filing | Oct 17, 2019 | — |
| DRSLTR | Filing | Oct 7, 2019 | — |
| DRS/A | Filing | Oct 7, 2019 | — |
| SEC STAFF LETTER | Filing | Sep 19, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 19, 2019 | — |
| DRS | Filing | Aug 23, 2019 | — |
| D/A | Filing | Jul 16, 2019 | — |
| D | Filing | Jan 3, 2019 | — |
| D | Filing | Aug 22, 2018 | — |
| D/A | Filing | Jan 4, 2018 | — |
| D | Filing | Mar 28, 2017 | — |
Showing 150 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BDTX (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1701541
- Former names
- Aset Therapeutics, Inc. (until Jan 4, 2018)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.